EMA Pharmacokinetics Working Party Meeting - Questions [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2020-05-04 09:41 (1614 d 01:18 ago) – Posting: # 21390
Views: 2,244

Dear All
I hope you are fine.
We were informed by BfArM that currently fundamental questions about FDCs are being finally discussed as examples within the PKWP. Has anybody an idea which questions these are?
—
Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,653 registered users;
56 visitors (0 registered, 56 guests [including 13 identified bots]).
Forum time: 10:59 CEST (Europe/Vienna)

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5